Safety Announcement
Additional Information for Patients
Additional Information for Healthcare Professionals
Data Summary

聽

Safety Announcement

References

1. Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. The Lancet Oncology 2010;11: 627-36.
2. Bangalore S, Kumar S, Kjeldsen SE, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomized trials. Lancet Oncol 2011;12: 65-82.
3. The ARB Trialists Collaboration. Effects of telmisartan, irbesartan, valsartan, and candesartan, and losartan on cancers in 15 trials. J Hypertens 2011;29: 623-635.
4. Pasternak B, Svanstr枚m H, Callr茅us T, et al. Use of angiotensin receptor blockers and the risk of cancer. Circulation 2011;123: 1729-36.

Posted: June 2011